BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20615375)

  • 1. [Lack of evidence to support chlamydia infection screening].
    Andersen B; Østergaard L; Olesen F
    Ugeskr Laeger; 2010 Jul; 172(28):2059-61. PubMed ID: 20615375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening.
    Land JA; Van Bergen JE; Morré SA; Postma MJ
    Hum Reprod Update; 2010; 16(2):189-204. PubMed ID: 19828674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chlamydia trachomatis].
    Ottesen M
    Ugeskr Laeger; 1996 Feb; 158(6):751-5. PubMed ID: 8638312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know?
    Gottlieb SL; Berman SM; Low N
    J Infect Dis; 2010 Jun; 201 Suppl 2():S156-67. PubMed ID: 20470051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunistic screening of young men for urogenital Chlamydia trachomatis infection in general practice.
    Andersen B; Eidner PO; Hagensen D; Lomborg S; Hoff G
    Scand J Infect Dis; 2005; 37(1):35-9. PubMed ID: 15764188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chlamydia trachomatis as an etiological factor of marital infertility--is a routine diagnostics worth to perform?].
    Murawski M; Matusiak M; Gryboś M
    Wiad Lek; 2007; 60(9-10):445-8. PubMed ID: 18350719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of Chlamydia trachomatis urogenital infections among the male and female population of the Republic of Macedonia.
    Spasovski MS; Simjanovska LJ; Taleski V; Petrova N; Lazetic L; Popeska Z; Gaydos CA; Quinn TC; Efremov GD
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):427-30. PubMed ID: 15987287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urine samples for screening of asymptomatic Chlamydia trachomatis infection in young male recruits].
    Jensen IP
    Ugeskr Laeger; 1993 May; 155(18):1376-8. PubMed ID: 8497970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses.
    van Valkengoed IG; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
    Int J Epidemiol; 2004 Apr; 33(2):416-25. PubMed ID: 15082651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Chlamydia trachomatis infection in infertile women at a university hospital in Jordan.
    Al-Ramahi M; Mahafzah A; Saleh S; Fram K
    East Mediterr Health J; 2008; 14(5):1148-54. PubMed ID: 19161088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of sequelae after Chlamydia trachomatis genital infection in women.
    Haggerty CL; Gottlieb SL; Taylor BD; Low N; Xu F; Ness RB
    J Infect Dis; 2010 Jun; 201 Suppl 2():S134-55. PubMed ID: 20470050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary: Chlamydia trachomatis screening: what are we trying to do?
    Peterman TA; Gottlieb SL; Berman SM
    Int J Epidemiol; 2009 Apr; 38(2):449-51. PubMed ID: 19174542
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for Chlamydia trachomatis infection.
    Skolnik NS
    Am Fam Physician; 1995 Mar; 51(4):821-6. PubMed ID: 7887358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The chlamydia epidemics is continuing--what should be done?].
    Paavonen J
    Duodecim; 2002; 118(13):1369-73. PubMed ID: 12239883
    [No Abstract]   [Full Text] [Related]  

  • 15. [Screening for Chlamydia trachomatis infection: which group should be targeted and at what price?].
    van Vloten WA
    Ned Tijdschr Geneeskd; 1999 Mar; 143(13):652-3. PubMed ID: 10321294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Coutinho RA; Jager JC
    Ned Tijdschr Geneeskd; 1999 Mar; 143(13):677-81. PubMed ID: 10321301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing genital chlamydia trachomatis infection in Scotland: targeted opportunistic testing or a screening programme?
    Clutterbuck DJ
    Health Bull (Edinb); 2001 Nov; 59(6):396-404. PubMed ID: 12661390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
    Norman JE; Wu O; Twaddle S; Macmillan S; McMillan L; Templeton A; McKenzie H; Noone A; Allardice G; Reid M
    BJOG; 2004 Nov; 111(11):1261-8. PubMed ID: 15521872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chlamydia trachomatis urogenital infections in women. Best diagnostic approaches].
    Hamdad F; Orfila J; Boulanger JC; Eb F
    Gynecol Obstet Fertil; 2004 Dec; 32(12):1064-74. PubMed ID: 15589784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlamydia screening programme, HMP Hydebank Wood Young Offender Centre, Belfast, Northern Ireland, UK.
    Hirst H; Dinsmore WW
    Int J STD AIDS; 2009 May; 20(5):360-1. PubMed ID: 19386977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.